Schrodinger is trading at $31.97, up 5.41%, with no clear company-specific announcement or September 30 catalyst identified. - Recent coverage points to a broader September rally and interest in computational drug discovery, but does not establish a cause for this intraday move. - In the supplied market context, the Nasdaq is up 0.91% and the S&P 500 is up 0.54%, offering a possible broader-market tailwind; this does not confirm the cause.